Alerts will be sent to your verified email
Verify EmailHEMORGANIC
Hemo Organic
|
Fabino Enterprises
|
Cresanto Global
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-343.55 % | 0.76 % | 4.33 % |
5yr average Equity Multiplier
|
4.83 | 2.01 | -0.1 |
5yr Average Asset Turnover Ratio
|
0.56 | 0.98 | 0.0 |
5yr Avg Net Profit Margin
|
-766.15 % | 0.54 % | 0.0 |
Price to Book
|
0.0 | 0.0 | 0.0 |
P/E
|
0.0 | 151.38 | 0.0 |
5yr Avg Cash Conversion Cycle
|
-1382.2 Days | 59.85 Days | 0.0 |
Inventory Days
|
364.55 Days | 81.8 Days | 0.0 |
Days Receivable
|
1156.1 Days | 131.05 Days | 0.0 |
Days Payable
|
2873.52 Days | 60.4 Days | 0.0 |
5yr Average Interest Coverage Ratio
|
-254.04 | 5.69 | -1369.03 |
5yr Avg ROCE
|
52.28 % | 1.29 % | -157.79 % |
5yr Avg Operating Profit Margin
|
-746.74 % | 1.24 % | 0.0 |
5 yr average Debt to Equity
|
1.23 | 0.14 | -0.41 |
5yr CAGR Net Profit
|
67.03 % | -4.36 % | 10.76 % |
5yr Average Return on Assets
|
-38.14 % | 0.49 % | -51.92 % |
Shareholdings
|
|||
Promoter Holding
|
16.85 % | 56.82 % | 32.27 % |
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
0.0 | 0.0 | 3.91 % |
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
Hemo Organic
|
Fabino Enterprises
|
Cresanto Global
|
|
---|---|---|---|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|